特一药业 - Financials

特一药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009
+Revenue	688.0M	1.1B	887.0M	758.0M	633.0M	921.0M	885.0M	687.0M	656.0M	517.0M	345.0M	343.0M	341.0M	305.0M	251.0M	202.0M
Revenue Growth %	-35.5%	20.3%	17.0%	19.7%	-31.3%	4.1%	28.8%	4.7%	26.9%	49.9%	0.6%	0.6%	11.8%	21.5%	24.3%	--
Total Revenue	688.0M	1.1B	887.0M	758.0M	633.0M	921.0M	885.0M	687.0M	656.0M	517.0M	345.0M	343.0M	341.0M	305.0M	251.0M	202.0M
Cost Of Revenue	386.0M	468.0M	452.0M	356.0M	327.0M	375.0M	364.0M	356.0M	343.0M	283.0M	192.0M	194.0M	199.0M	184.0M	164.0M	151.0M
+Gross Profit	302.0M	599.0M	435.0M	402.0M	306.0M	546.0M	521.0M	331.0M	313.0M	234.0M	153.0M	149.0M	142.0M	121.0M	87.0M	51.0M
Gross Margin %	43.9%	56.1%	49.0%	53.0%	48.3%	59.3%	58.9%	48.2%	47.7%	45.3%	44.3%	43.4%	41.6%	39.7%	34.7%	25.2%
Total Operating Cost	674.0M	782.0M	699.0M	628.0M	593.0M	742.0M	722.0M	577.0M	555.0M	425.0M	254.0M	249.0M	253.0M	228.0M	197.0M	175.0M
Selling Expenses	151.0M	174.0M	117.0M	119.0M	98.9M	206.0M	200.0M	103.0M	89.7M	74.4M	35.9M	28.2M	24.8M	18.4M	14.3M	6.6M
Admin Expenses	74.4M	66.3M	59.0M	57.2M	55.0M	61.6M	56.4M	45.3M	97.4M	64.2M	31.2M	27.4M	25.7M	23.9M	17.2M	14.2M
Rd Expenses	43.3M	43.1M	38.0M	37.8M	36.5M	44.4M	46.6M	46.2M	--	--	--	--	--	--	--	--
Finance Expenses	-716,300	4.8M	21.4M	24.0M	41.5M	45.2M	39.7M	17.5M	16.9M	-311,500	-6.6M	-3.0M	-2.0M	-99,100	657,300	1.3M
+Operating Income	24.1M	293.0M	197.0M	141.0M	58.2M	198.0M	182.0M	117.0M	100.0M	91.8M	90.3M	93.3M	88.3M	77.0M	53.5M	27.2M
Operating Margin %	3.5%	27.5%	22.2%	18.6%	9.2%	21.5%	20.6%	17.0%	15.2%	17.8%	26.2%	27.2%	25.9%	25.3%	21.3%	13.5%
Non Operating Income	44,200	106,800	74,100	7.6M	213,500	2,400	128,000	3.2M	5.2M	4.7M	2.7M	230,000	3.4M	4.2M	2.5M	839,500
Non Operating Expenses	2.1M	384,200	297,400	1.1M	5.2M	719,100	4.9M	569,500	293,800	1.2M	23,900	31,000	310,000	221,000	100,400	22,700
Investment Income	3.7M	360,800	339,500	6.3M	15.2M	5.5M	11.4M	--	--	--	--	--	--	--	--	--
Asset Disposal Income	8,200	122,100	40,800	95,300	-292,700	2,100	--	600.00	44,100	--	--	--	--	--	--	--
Asset Impairment Loss	12.4M	13.2M	--	23.1M	26.3M	104,600	3.1M	-3,200	799,000	425,100	-1.6M	155,200	2.1M	-87,400	159,900	526,500
Other Income	6.8M	7.6M	8.5M	4.0M	3.2M	13.4M	7.8M	6.8M	--	--	--	--	--	--	--	--
Income Before Tax	22.1M	293.0M	196.0M	147.0M	53.3M	197.0M	177.0M	120.0M	105.0M	95.3M	93.0M	93.5M	91.4M	81.0M	55.9M	28.0M
Income Tax	1.6M	39.8M	18.1M	20.2M	9.5M	25.1M	21.6M	13.3M	10.6M	14.1M	12.8M	12.9M	12.8M	11.3M	7.9M	3.9M
+Net Income	20.5M	253.0M	178.0M	127.0M	43.8M	172.0M	156.0M	106.0M	94.8M	81.1M	80.2M	80.6M	78.6M	69.7M	48.0M	24.1M
Net Margin %	3.0%	23.7%	20.1%	16.8%	6.9%	18.7%	17.6%	15.4%	14.4%	15.7%	23.2%	23.5%	23.0%	22.9%	19.1%	11.9%
Net Income Attributable	20.5M	253.0M	178.0M	127.0M	43.8M	172.0M	156.0M	106.0M	94.8M	81.1M	80.2M	80.6M	78.6M	69.7M	48.0M	24.1M
Eps Basic	0.04	0.55	0.57	0.62	0.22	0.85	0.78	0.53	0.47	0.41	0.47	1.07	1.05	0.93	0.66	0.35
Eps Diluted	0.04	0.55	0.57	0.62	0.22	0.84	0.78	0.53	0.47	0.41	0.47	1.07	1.05	0.93	0.66	0.35

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009
Cash And Equivalents	457.0M	647.0M	740.0M	372.0M	325.0M	124.0M	461.0M	217.0M	154.0M	245.0M	500.0M	163.0M	150.0M	90.8M	57.2M	19.5M
Trading Financial Assets	--	--	--	--	250.0M	450.0M	--	--	--	--	--	--	--	--	--	--
Accounts Receivable	98.7M	97.8M	93.5M	77.0M	70.8M	93.2M	91.7M	60.8M	59.2M	87.0M	39.8M	39.2M	33.3M	27.6M	27.8M	25.3M
Notes Receivable	107.0M	58.2M	39.6M	49.7M	71.4M	58.5M	68.6M	57.3M	70.0M	80.4M	59.1M	51.8M	34.9M	23.2M	18.8M	23.5M
Notes And Accounts Receivable	205.0M	156.0M	133.0M	127.0M	142.0M	152.0M	160.0M	118.0M	129.0M	167.0M	98.9M	91.0M	68.2M	50.8M	46.6M	48.8M
Prepayments	10.4M	14.4M	27.8M	14.5M	13.3M	13.0M	18.6M	9.9M	29.0M	59.9M	32.2M	18.1M	25.9M	10.0M	28.8M	6.8M
Inventory	264.0M	272.0M	208.0M	195.0M	193.0M	195.0M	178.0M	187.0M	158.0M	161.0M	59.6M	62.9M	75.8M	74.6M	63.8M	55.4M
Total Current Assets	951.0M	1.1B	1.1B	712.0M	929.0M	935.0M	825.0M	789.0M	472.0M	638.0M	694.0M	336.0M	321.0M	227.0M	197.0M	131.0M
Fixed Assets	--	525.0M	367.0M	403.0M	435.0M	441.0M	321.0M	332.0M	275.0M	231.0M	64.9M	57.0M	40.3M	34.9M	36.7M	39.3M
Fixed Assets Total	564.0M	525.0M	367.0M	403.0M	435.0M	441.0M	321.0M	332.0M	275.0M	231.0M	64.9M	57.0M	40.3M	34.9M	36.7M	39.3M
Construction In Progress	--	132.0M	281.0M	198.0M	119.0M	81.6M	160.0M	125.0M	74.6M	60.8M	48.9M	42.1M	8.1M	2.6M	--	--
Construction In Progress Total	158.0M	132.0M	281.0M	198.0M	119.0M	81.6M	160.0M	125.0M	74.6M	60.8M	48.9M	42.1M	8.1M	2.6M	--	--
Intangible Assets	139.0M	151.0M	154.0M	157.0M	132.0M	132.0M	128.0M	70.7M	73.9M	77.3M	17.3M	17.7M	18.2M	18.7M	19.1M	19.4M
Long Term Deferred Expenses	--	52,500	122,500	192,500	262,500	332,500	--	67,000	147,400	227,800	--	--	--	--	--	--
Total Non Current Assets	1.4B	1.4B	1.4B	1.4B	1.3B	1.3B	1.2B	1.1B	1.1B	961.0M	131.0M	117.0M	67.1M	56.4M	56.1M	58.9M
Total Assets	2.4B	2.5B	2.5B	2.1B	2.3B	2.3B	2.1B	1.9B	1.6B	1.6B	826.0M	454.0M	388.0M	283.0M	253.0M	190.0M
Short Term Borrowings	516.0M	306.0M	634.0M	377.0M	770.0M	642.0M	392.0M	249.0M	225.0M	172.0M	--	--	--	--	12.6M	36.5M
Accounts Payable	34.5M	41.9M	63.1M	44.0M	29.7M	38.2M	28.1M	31.3M	32.4M	40.3M	14.8M	20.3M	16.2M	11.0M	12.7M	14.8M
Advance Receipts	--	--	--	--	--	14.6M	27.4M	41.1M	25.4M	18.9M	6.5M	7.7M	2.9M	3.3M	3.5M	646,800
Contract Liabilities	11.0M	24.3M	131.0M	31.1M	26.1M	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	596.0M	466.0M	1.1B	496.0M	878.0M	773.0M	535.0M	430.0M	517.0M	592.0M	82.7M	96.5M	96.7M	57.7M	81.9M	86.5M
Long Term Borrowings	--	--	--	--	--	11.5M	117.0M	153.0M	178.0M	178.0M	--	--	--	--	--	--
Total Non Current Liabilities	39.9M	36.2M	33.2M	308.0M	297.0M	331.0M	421.0M	456.0M	199.0M	202.0M	7.2M	6.9M	6.2M	--	--	--
Total Liabilities	636.0M	502.0M	1.1B	805.0M	1.2B	1.1B	956.0M	886.0M	717.0M	794.0M	90.0M	103.0M	103.0M	57.7M	81.9M	86.5M
Paid In Capital	512.0M	365.0M	229.0M	222.0M	204.0M	201.0M	201.0M	200.0M	200.0M	200.0M	100.0M	75.0M	75.0M	75.0M	75.0M	69.0M
Capital Reserve	844.0M	982.0M	576.0M	461.0M	293.0M	252.0M	252.0M	238.0M	238.0M	238.0M	338.0M	41.1M	41.1M	41.1M	41.1M	17.1M
Surplus Reserve	142.0M	140.0M	115.0M	111.0M	102.0M	95.2M	77.7M	64.6M	49.9M	43.6M	37.4M	29.4M	21.3M	13.5M	6.5M	1.7M
Retained Earnings	353.0M	518.0M	439.0M	409.0M	423.0M	538.0M	515.0M	472.0M	396.0M	320.0M	260.0M	205.0M	148.0M	95.9M	48.2M	15.4M
Equity Attributable	1.8B	2.0B	1.4B	1.3B	1.1B	1.2B	1.1B	1.0B	887.0M	804.0M	736.0M	350.0M	285.0M	226.0M	171.0M	103.0M
Total Equity	1.8B	2.0B	1.4B	1.3B	1.1B	1.2B	1.1B	1.0B	887.0M	804.0M	736.0M	350.0M	285.0M	226.0M	171.0M	103.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009
Cash From Sales	621.0M	925.0M	950.0M	764.0M	668.0M	998.0M	970.0M	746.0M	717.0M	564.0M	360.0M	371.0M	358.0M	353.0M	289.0M	205.0M
Total Operating Cash Inflow	633.0M	946.0M	972.0M	776.0M	676.0M	1.0B	988.0M	754.0M	726.0M	581.0M	367.0M	374.0M	364.0M	358.0M	292.0M	206.0M
Cash Paid For Goods	313.0M	351.0M	299.0M	238.0M	238.0M	350.0M	372.0M	375.0M	340.0M	323.0M	193.0M	195.0M	157.0M	213.0M	187.0M	147.0M
Cash Paid To Employees	103.0M	108.0M	89.9M	86.3M	77.3M	91.6M	79.8M	72.3M	70.8M	48.9M	25.0M	21.4M	18.1M	15.6M	10.3M	6.9M
Taxes Paid	62.6M	102.0M	67.5M	67.9M	64.1M	121.0M	96.2M	75.3M	75.5M	44.8M	39.5M	41.0M	45.0M	32.0M	20.6M	16.2M
Total Operating Cash Outflow	655.0M	748.0M	600.0M	519.0M	507.0M	795.0M	800.0M	651.0M	625.0M	513.0M	309.0M	300.0M	259.0M	288.0M	245.0M	184.0M
Operating Cash Flow	-22.5M	199.0M	372.0M	257.0M	169.0M	222.0M	188.0M	103.0M	101.0M	68.9M	57.3M	74.2M	105.0M	69.8M	46.9M	22.3M
Total Investing Cash Inflow	896.0M	73.5M	40.4M	293.0M	748.0M	410.0M	582.0M	193,900	1.3M	95.7M	--	2.9M	10.9M	21.9M	15.5M	2.7M
Total Investing Cash Outflow	1.0B	159.0M	144.0M	146.0M	622.0M	985.0M	518.0M	341.0M	243.0M	763.0M	27.0M	46.1M	35.1M	18.5M	25.2M	19.5M
Investing Cash Flow	-110.0M	-85.5M	-103.0M	147.0M	126.0M	-575.0M	63.7M	-341.0M	-242.0M	-668.0M	-27.0M	-43.1M	-24.2M	3.4M	-9.7M	-16.8M
Cash From Borrowings	1.0B	627.0M	763.0M	433.0M	793.0M	649.0M	455.0M	286.0M	315.0M	348.0M	--	--	--	10.0M	18.6M	59.5M
Dividends And Interest Paid	182.0M	149.0M	148.0M	138.0M	164.0M	150.0M	118.0M	31.9M	30.0M	17.4M	16.5M	15.8M	18.8M	15.4M	11.1M	7.7M
Debt Repayments	809.0M	966.0M	517.0M	836.0M	723.0M	483.0M	314.0M	255.0M	222.0M	4.0M	--	--	--	22.6M	43.4M	58.0M
Total Financing Cash Inflow	1.6B	1.1B	763.0M	618.0M	793.0M	649.0M	455.0M	634.0M	318.0M	365.0M	330.0M	716,900	6.2M	10.0M	48.6M	59.5M
Total Financing Cash Outflow	1.7B	1.2B	865.0M	975.0M	887.0M	632.0M	463.0M	333.0M	269.0M	21.4M	23.2M	16.2M	19.3M	38.6M	54.5M	65.8M
Financing Cash Flow	-112.0M	-105.0M	-101.0M	-357.0M	-93.3M	16.5M	-7.7M	301.0M	49.5M	343.0M	307.0M	-15.5M	-13.1M	-28.6M	-5.9M	-6.2M
Net Change In Cash	-244.0M	7.6M	167.0M	47.3M	202.0M	-337.0M	244.0M	62.7M	-91.4M	-255.0M	337.0M	15.6M	67.2M	44.7M	31.3M	-754,800
Ending Cash Balance	303.0M	547.0M	539.0M	372.0M	325.0M	123.0M	460.0M	216.0M	154.0M	245.0M	500.0M	163.0M	147.0M	80.0M	35.3M	4.0M
Capex	114.0M	86.0M	90.3M	110.0M	89.4M	131.0M	152.0M	40.6M	171.0M	101.0M	27.0M	46.1M	32.2M	7.7M	3.3M	4.0M